SteinCares
  • Home
  • Company
    • Who We are
    • Our Milestones
    • Our Presence
  • Business Segments
    • Innovative
    • Biosimilars
    • Complex Generics
    • Therapeutic Areas
  • Partnerships
    • Pillars of Successful Partnerships
    • Our Partnership Solutions
  • Press Releases
  • Contact us
  • ESP
Select Page
SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil

SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil

by victoria.carrillo | Mar 26, 2026 | Press Releases

ANVISA approval for the Spectrila® marketing authorization transfer enables SteinCares to ensure uninterrupted access to essential Acute Lymphoblastic Leukemia (ALL) treatment in Brazil. The milestone strengthens SteinCares’ onco-hematology portfolio and...
Bio-Thera Solutions and SteinCares Expand Partnership with Addition of a Third Biosimilar in LATAM 

Bio-Thera Solutions and SteinCares Expand Partnership with Addition of a Third Biosimilar in LATAM 

by victoria.carrillo | Dec 19, 2024 | Press Releases

GUANGZHOU, China and San Jose, Costa Rica – SteinCares, a leading specialty healthcare company in Latin America, and Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced an expansion...

Recent Posts

  • SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil
  • SteinCares and Shilpa Biologicals Strike into licensing agreement to Expand Access to Biosimilars Across Latin America
  • SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance
  • SteinCares Expands its Portfolio in Brazil with Monofer®
  • SteinCares Opens New Facility in Costa Rica to Strengthen Access to Specialty Healthcare Across Latin America

Recent Comments

No comments to show.